| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/14/2005 | CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | CA2540665A1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/14/2005 | CA2540521A1 Anti-nik antibodies and uses thereof |
| 04/14/2005 | CA2537326A1 C1q related protein |
| 04/14/2005 | CA2526425A1 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 04/13/2005 | EP1521968A1 Secreted polypeptide species associated with cardiovascular disorders |
| 04/13/2005 | EP1521967A2 Plasma urotensin in human heart failure |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521776A2 Neoplasm specific antibodies and uses thereof |
| 04/13/2005 | EP1521775A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1521591A1 Use of pthrp antagonists for treating renal cell carcinoma |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/13/2005 | CN1606455A Lyophilized preparation containing antibodies to the egf receptor |
| 04/13/2005 | CN1606454A Antibody targeting compounds |
| 04/13/2005 | CN1606453A Cripto blocking antibodies and uses thereof |
| 04/13/2005 | CN1605628A Human source anti-hepatitis A virus gene engineering antibody from CHO cell |
| 04/13/2005 | CN1605591A Labelled molecule capable of identifying reactive astrocytes and use thereof |
| 04/13/2005 | CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
| 04/13/2005 | CN1196714C Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878528 Polynucleotides encoding a mammalian Langerhans cell antigen |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878376 Modulate immunology response |
| 04/12/2005 | US6878375 HA-1 antigen |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/12/2005 | CA2113813C Immunoglobulin variants for specific fc epsilon receptors |
| 04/12/2005 | CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 04/12/2005 | CA2074825C Chimeric chains for receptor-associated signal transduction pathways |
| 04/07/2005 | WO2005031360A1 Method of detecting or discriminating articular rheumatism and method of determining stage of disease or degree of dysfunction |
| 04/07/2005 | WO2005031309A2 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 04/07/2005 | WO2005030961A1 Novel nerve stem cell marker |
| 04/07/2005 | WO2005030939A2 Method and composition for regulating expansion of stem cells |
| 04/07/2005 | WO2005030931A2 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 04/07/2005 | WO2005030806A2 Norovirus monoclonal antibodies and peptides |
| 04/07/2005 | WO2005030805A1 Novel protein complex and use thereof |
| 04/07/2005 | WO2005030798A2 TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS- |
| 04/07/2005 | WO2005030793A2 Antibodies which bind human cxcr3 |
| 04/07/2005 | WO2005030252A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 04/07/2005 | WO2005030251A1 Compositions and methods to accelerate hematologic recovery |
| 04/07/2005 | WO2005030139A2 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | WO2005030124A2 Antibodies to m-csf |
| 04/07/2005 | WO2005030123A2 Botulinum antitoxin compositions and methods |
| 04/07/2005 | WO2005030119A2 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 04/07/2005 | WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation |
| 04/07/2005 | WO2004111608A3 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 04/07/2005 | WO2004108159A3 Gb virus c (hepatitis g virus) for the treatment of hiv |
| 04/07/2005 | WO2004096976A3 Spex compositions and methods of use |
| 04/07/2005 | WO2004073741A8 Remedy for spinal injury containing interleukin-6 antagonist |
| 04/07/2005 | WO2004069875A3 Immunoglobulin anti integrin |
| 04/07/2005 | WO2004066957A3 ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF |
| 04/07/2005 | WO2004062462A8 Monclonal anitbodies to rna binding protein gw182 |
| 04/07/2005 | WO2004032857A8 Antibody therapy |
| 04/07/2005 | WO2004029092A8 Antibody for adcc and inducing cytokine production |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | WO2003072063A3 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 04/07/2005 | WO2003065981A3 Therapeutic use for lp229, in particular for wound healing |
| 04/07/2005 | US20050076406 Plant-derived resistance gene |
| 04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
| 04/07/2005 | US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075488 Interleukin-1 beta antibodies |
| 04/07/2005 | US20050075487 Agents that bind to and inhibit human cytochrome P450 2C8, 2C9, 2C18 and 2C19 |
| 04/07/2005 | US20050075486 A monoclonal antibody produced by hybridoma deposited as 96-109FE8 IH11 which agglutinates bacteria bearing CS4-CFA/I family of proteins and binds exclusively and specifically to amino acid sequence serine-alanine-valine-alanine-leucine-threonine-tyrosine-serine |
| 04/07/2005 | US20050075484 Construction and use of synthetic constructs encoding syndecan |
| 04/07/2005 | US20050075102 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls |
| 04/07/2005 | US20050074855 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 04/07/2005 | US20050074854 Glycosylated specificity exchangers |
| 04/07/2005 | US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/07/2005 | US20050074848 Major histocompatibility complex fusion comprising human cartilage oligomeric matrix protein (COMP) for use in prevention and treatment of cancer, infection, autoimmune and transplant rejection |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074826 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 04/07/2005 | US20050074823 Monoclonal antibody for use in treatment and prevention of pathogen infection |
| 04/07/2005 | US20050074821 Nerve growth factor specific immunoglobulin for prevention and treatment of chronic pain, nervous system, inflammatory, skin and bone disorders |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074749 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 04/07/2005 | US20050074464 Type I allergic diseases; grass pollen |
| 04/07/2005 | US20050074454 Methods of treating carcinoma using anti-TNF antibodies and peptides |
| 04/07/2005 | US20050074453 Preventing scar formation; introducing human recombinant phage antibody into area following operation |